Clinical Trials Browser

Phase 3 × 4-chloro-N-(2-furylmethyl)-5-sulfamoylanthranilic acid × 1 year × Clear all

Brain Neoplasms, Neuroblastoma, Parkinson Disease, Neuroendocrine Tumors, Lewy Body Disease, Congenital Hyperinsulinism